C21H25ClO8
Neat
440.87
Dapagliflozin impurity A; 2452300-94-4; (2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-[(4-ethoxyphenyl)-hydroperoxymethyl]phenyl]-6-(hydroxymethyl)oxane-3, 4, 5-triol; Dapagliflozin peroxide impurity; SCHEMBL28411766; (2S, 3R, 4R, 5S, 6R)-2-(4-Chloro-3-((4-ethoxyphenyl)(hydroperoxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3, 4, 5-triol; DA-52307; HY-400785; CS-0905213; G87535; Dapagliflozin Impurity POE (hydroperoxy impurity); Dapagliflozin Peroxide Impurity; (2S, 3R, 4R, 5S, 6R)-2-(4-chloro-3-((4-ethoxyphenyl)(hydroperoxy)methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3, 4 and 5-triol
(2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-[(4-ethoxyphenyl)-hydroperoxymethyl]phenyl]-6-(hydroxymethyl)oxane-3, 4 and 5-triol
InChI=1S/C21H25ClO8/c1-2-28-13-6-3-11(4-7-13)20(30-27)14-9-12(5-8-15(14)22)21-19(26)18(25)17(24)16(10-23)29-21/h3-9,16-21,23-27H,2,10H2,1H3/t16-,17-,18+,19-,20?,21+/m1/s1